Brind.

Entities / Company

Daiichi Sankyo (United Kingdom).

company in Chalfont Saint Peter, United Kingdom

Seen in 10 reportsLast reported May 20

Reports this week: 0
Active events: 0
Connections: 10

What's happening

Gone quiet

No new reports in 90+ days

AstraZeneca formed a partnership with Daiichi Sankyo regarding Enhertu, and also established a profit-sharing deal with Merck for Lynparza.

Some support3 reports1 development inside

Around Daiichi Sankyo (United Kingdom) this week

News at the entities that move Daiichi Sankyo (United Kingdom) most

AstraZeneca Operational
AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.

Moves Daiichi Sankyo (United Kingdom)
Mon 11:04

Connections

The 1 strongest of 10, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

AstraZeneca Operational

AstraZeneca and Daiichi Sankyo maintain a formal partnership and licensing agreement for the drug Enhertu.

SpeculativeAug 15

Daiichi Sankyo (United Kingdom) → AstraZeneca
AstraZeneca → Daiichi Sankyo (United Kingdom)

History

Events by the month they began

June 2026

1 event

Jun 7, 2026AstraZeneca formed a partnership with Daiichi Sankyo regarding Enhertu, and also established a profit-sharing deal with Merck for Lynparza.